← All stocks

MACROGENICS INC

MGNX Net buying
CIK 0001125345 #3730 in the set updated 18 Sep 2026
Bought (120 mo)
$38.92M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$12.61M
$1.63M on a plan · $8.25M straight out of an exercise
Sold at will
$2.73M
8 of 69 sales
Net
+$26.31M
+$36.19M against sales at will

By person

23 insiders · 131 transactions
0.5×

Eric Risser holds only 0.5 times base salary in stock. $320.25K of shares against $561.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Eric Risser last reported holding, valued at $4.15, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BIOTECH TARGET N V
10% owner
$38.60M (19)
+$38.60M
9,929,963
15.59%
$41.21M
+64.8%
Peters Jeffrey Stuart
Senior VP, GC, and Secretary
$3.50M (14) scheduled
−$3.50M
0
0.0000%
$0.00
−100.0%
Bonvini Ezio
Sr VP, Research & CSO
$2.65M (7)
−$2.65M
185,799
0.2917%
$771.07K
+111.0%
Risser Eric Blasius
President and CEO
$1.63M (26) scheduled
−$1.63M
77,169
0.1211%
$320.25K
+985.5%
Karrels James
SVP and CFO
$98.80K (1)
$1.27M (3)
−$1.17M
206,037
0.3234%
$855.05K
+105.4%
Wigginton Jon Marc
Sr VP, Clinical Dev. & CMO
$1.09M (7) scheduled
−$1.09M
18,930
0.0297%
$78.56K
−36.9%
Spitznagel Thomas
Sr VP, Technical Ops
$923.98K (6) scheduled
−$923.98K
38,543
0.0605%
$159.95K
Cilinski Lynn
VP, Controller and Treasurer
$781.88K (2) scheduled
−$781.88K
6,213
0.0098%
$25.78K
+223.1%
Galbraith Kenneth
Director
$563.16K (2) scheduled
−$563.16K
0
0.0000%
$0.00
Fust Matthew K
Director
$203.43K (1) scheduled
−$203.43K
500
0.0008%
$2.08K
0.0%
HEIDEN WILLIAM K
Director
$150.52K (2)
+$150.52K
114,750
0.1801%
$476.21K
HURWITZ EDWARD
Director
$73.65K (1)
+$73.65K
47,824
0.0751%
$198.47K
+164.6%
Smith Beth Ann
VP, Controller & Treasurer
$1.08K (1) scheduled
−$1.08K
12,781
0.0201%
$53.04K
+62.0%
Koenig Scott
Director
2,165,915
3.40%
$8.99M
+33.1%
Eck Stephen L.
Chief Medical Officer
29,377
0.0461%
$121.91K
SARAN ATUL
SVP & General Counsel
16,986
0.0267%
$70.49K
−9.9%
Ferrante Karen Jean
Director
14,750
0.0232%
$61.21K
STUMP DAVID C
Director
14,750
0.0232%
$61.21K
O'Brien Federica F.
Director
14,750
0.0232%
$61.21K
Jackson Scott Thomas
Director
14,750
0.0232%
$61.21K
SIEGEL JAY PHILIP
Director
14,750
0.0232%
$61.21K
Liu Margaret
Director
14,750
0.0232%
$61.21K
Chhabra Meenu
Director
14,750
0.0232%
$61.21K
Insider
Date
Role
Action
Shares
Price
Amount
Peters Jeffrey Stuart
19 Aug 2026
Senior VP, GC, and Secretary
Sold on a plan
31,105
$4.15
$129.09K
Bonvini Ezio
17 Aug 2026
Sr VP, Research & CSO
Exercised, kept
40,000
$2.60
$104.00K
HEIDEN WILLIAM K
20 Aug 2025
Director
Buy
49,500
$1.49
$73.76K
HEIDEN WILLIAM K
19 Aug 2025
Director
Buy
50,500
$1.52
$76.76K
Smith Beth Ann
15 Feb 2025
VP, Controller & Treasurer
Sold after exercise
423
$2.56
$1.08K
Peters Jeffrey Stuart
4 Apr 2024
Senior VP and General Counsel
Sold after exercise
3,165
$18.22
$57.67K
Peters Jeffrey Stuart
4 Apr 2024
Senior VP and General Counsel
Sold after exercise
5,351
$17.74
$94.93K
Peters Jeffrey Stuart
4 Apr 2024
Senior VP and General Counsel
Sold after exercise
232
$16.38
$3.80K
Peters Jeffrey Stuart
4 Apr 2024
Senior VP and General Counsel
Sold after exercise
147
$15.51
$2.28K
Peters Jeffrey Stuart
4 Apr 2024
Senior VP and General Counsel
Sold after exercise
42,500
$15.07
$640.48K
Peters Jeffrey Stuart
6 Mar 2024
Senior VP and General Counsel
Sold after exercise
19,625
$21.50
$421.94K
Karrels James
4 Mar 2024
SVP, CFO and Secretary
Sold on a plan
30,000
$20.50
$615.00K
Spitznagel Thomas
4 Mar 2024
Sr VP, Technical Ops
Sold after exercise
10,000
$20.00
$200.00K
Risser Eric Blasius
4 Mar 2024
Chief Operating Officer
Sold after exercise
26,159
$19.63
$513.50K
Risser Eric Blasius
4 Mar 2024
Chief Operating Officer
Sold after exercise
15,000
$20.00
$300.00K
Peters Jeffrey Stuart
26 Feb 2024
Senior VP and General Counsel
Sold on a plan
16,124
$17.22
$277.66K
Bonvini Ezio
7 Feb 2024
Sr VP, Research & CSO
Sold on a plan
3,334
$18.00
$60.01K
Peters Jeffrey Stuart
5 Feb 2024
Senior VP and General Counsel
Sold after exercise
21,875
$16.50
$360.94K
Peters Jeffrey Stuart
5 Feb 2024
Senior VP and General Counsel
Sold after exercise
54,376
$16.50
$897.20K
Bonvini Ezio
1 Feb 2024
Sr VP, Research & CSO
Sold on a plan
13,316
$15.00
$199.74K
Bonvini Ezio
19 Jan 2024
Sr VP, Research & CSO
Sold on a plan
13,316
$12.00
$159.79K
Bonvini Ezio
20 Dec 2023
Sr VP, Research & CSO
Sold on a plan
18,880
$10.08
$190.31K
BIOTECH TARGET N V
2 Oct 2023
10% owner
Buy
150,000
$4.46
$669.59K
BIOTECH TARGET N V
7 Sep 2023
10% owner
Buy
200,000
$5.26
$1.05M
HURWITZ EDWARD
30 Aug 2023
Director
Buy
15,000
$4.91
$73.65K
Peters Jeffrey Stuart
10 Mar 2023
Senior VP and General Counsel
Sell
5,372
$6.03
$32.39K
BIOTECH TARGET N V
14 Feb 2023
10% owner
Buy
500,000
$5.07
$2.53M
BIOTECH TARGET N V
19 Jan 2023
10% owner
Buy
150,000
$5.30
$794.93K
BIOTECH TARGET N V
27 Dec 2022
10% owner
Buy
200,000
$5.61
$1.12M
BIOTECH TARGET N V
23 Dec 2022
10% owner
Buy
200,000
$5.88
$1.18M
BIOTECH TARGET N V
22 Nov 2022
10% owner
Buy
300,000
$5.96
$1.79M
Risser Eric Blasius
28 Oct 2022
Chief Operating Officer
Exercised, kept
8,500
$1.51
$12.84K
BIOTECH TARGET N V
24 Oct 2022
10% owner
Buy
250,000
$4.36
$1.09M
BIOTECH TARGET N V
21 Oct 2022
10% owner
Buy
250,000
$4.63
$1.16M
BIOTECH TARGET N V
20 Oct 2022
10% owner
Buy
285,977
$4.00
$1.14M
BIOTECH TARGET N V
19 Oct 2022
10% owner
Buy
168,422
$3.70
$623.92K
Karrels James
15 Jun 2022
SVP, CFO and Secretary
Buy
40,000
$2.47
$98.80K
Koenig Scott
16 May 2022
President and CEO
Exercised, kept
53,265
$1.51
$80.43K
Karrels James
28 Mar 2022
SVP, CFO and Secretary
Exercised, kept
8,316
$1.51
$12.56K
Risser Eric Blasius
4 Mar 2022
Chief Operating Officer
Exercised, kept
500
$0.94
$470.00
BIOTECH TARGET N V
19 Nov 2021
10% owner
Buy
200,000
$18.50
$3.70M
Bonvini Ezio
16 Nov 2021
Sr VP, Research & CSO
Exercised, kept
2,540
$16.00
$40.64K
BIOTECH TARGET N V
29 Sep 2021
10% owner
Buy
100,000
$20.47
$2.05M
BIOTECH TARGET N V
28 Sep 2021
10% owner
Buy
100,000
$20.64
$2.06M
BIOTECH TARGET N V
17 Sep 2021
10% owner
Buy
200,000
$19.93
$3.99M
BIOTECH TARGET N V
16 Sep 2021
10% owner
Buy
400,000
$20.94
$8.38M
Spitznagel Thomas
16 Jul 2021
Sr VP, BPD & Manufacturing
Sold after exercise
5,000
$25.01
$125.05K
Bonvini Ezio
24 Jun 2021
Sr VP, Research & CSO
Exercised, kept
4,221
$20.53
$86.66K
Bonvini Ezio
24 Jun 2021
Sr VP, Research & CSO
Exercised, kept
21,855
$16.00
$349.68K
BIOTECH TARGET N V
21 Jun 2021
10% owner
Buy
75,000
$21.74
$1.63M
BIOTECH TARGET N V
16 Jun 2021
10% owner
Buy
100,000
$21.04
$2.10M
BIOTECH TARGET N V
15 Jun 2021
10% owner
Buy
75,000
$20.53
$1.54M
Spitznagel Thomas
15 Apr 2021
Sr VP, BPD & Manufacturing
Sold after exercise
5,000
$30.91
$154.55K
Bonvini Ezio
22 Mar 2021
Sr VP, Research & CSO
Sell
3,917
$32.00
$125.34K
Karrels James
22 Mar 2021
SVP, CFO and Secretary
Sell
15,000
$33.00
$495.00K
Peters Jeffrey Stuart
8 Mar 2021
General Counsel
Sold after exercise
21,749
$26.50
$576.35K
Karrels James
28 Jan 2021
SVP, CFO and Secretary
Exercised, kept
5,000
$1.51
$7.55K
Karrels James
28 Jan 2021
SVP, CFO and Secretary
Exercised, kept
1,000
$0.94
$940.00
Risser Eric Blasius
29 Dec 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$24.10
$12.05K
Risser Eric Blasius
30 Nov 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$23.35
$11.68K
Risser Eric Blasius
28 Oct 2020
Sr VP & Chief Business Officer
Sold after exercise
1,500
$20.69
$31.04K
Risser Eric Blasius
28 Sep 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$25.33
$12.67K
Bonvini Ezio
18 Sep 2020
Sr VP, Research & CSO
Sell
18,339
$32.00
$586.85K
Bonvini Ezio
17 Sep 2020
Sr VP, Research & CSO
Sell
44,512
$29.88
$1.33M
Galbraith Kenneth
9 Sep 2020
Director
Sold after exercise
6,924
$27.11
$187.71K
Galbraith Kenneth
9 Sep 2020
Director
Sold after exercise
13,849
$27.11
$375.45K
Risser Eric Blasius
26 Aug 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$27.10
$13.55K
Spitznagel Thomas
20 Aug 2020
Sr VP, BPD & Manufacturing
Sold after exercise
7,500
$26.87
$201.53K
Risser Eric Blasius
27 Jul 2020
Sr VP & Chief Business Officer
Sold after exercise
3,000
$25.63
$76.89K
Risser Eric Blasius
27 Jul 2020
Sr VP & Chief Business Officer
Sold after exercise
1,000
$25.14
$25.14K
Risser Eric Blasius
27 Jul 2020
Sr VP & Chief Business Officer
Sold after exercise
489
$25.13
$12.29K
Risser Eric Blasius
2 Jul 2020
Sr VP & Chief Business Officer
Sold after exercise
3,100
$30.00
$93.00K
Peters Jeffrey Stuart
2 Jul 2020
General Counsel
Sell
202
$30.00
$6.06K
Risser Eric Blasius
24 Jun 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$28.49
$14.25K
Risser Eric Blasius
26 May 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$26.59
$13.30K
Spitznagel Thomas
20 May 2020
Sr VP, BPD & Manufacturing
Sold after exercise
7,500
$25.30
$189.75K
Risser Eric Blasius
6 May 2020
Sr VP & Chief Business Officer
Sold after exercise
3,532
$25.00
$88.30K
Risser Eric Blasius
6 May 2020
Sr VP & Chief Business Officer
Sold after exercise
3,000
$20.00
$60.00K
Risser Eric Blasius
6 May 2020
Sr VP & Chief Business Officer
Sold after exercise
1,000
$15.00
$15.00K
Risser Eric Blasius
6 May 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$10.00
$5.00K
Risser Eric Blasius
16 Apr 2020
Sr VP & Chief Business Officer
Exercised, kept
6,000
$0.94
$5.64K
Risser Eric Blasius
13 Mar 2020
Sr VP & Chief Business Officer
Exercised, kept
6,000
$0.94
$5.64K
Koenig Scott
11 Mar 2020
President and CEO
Exercised, kept
133,163
$0.94
$125.17K
Karrels James
6 Mar 2020
SVP, CFO and Secretary
Exercised, kept
4,473
$0.94
$4.20K
Risser Eric Blasius
20 Feb 2020
Sr VP & Chief Business Officer
Sold after exercise
500
$10.84
$5.42K
Risser Eric Blasius
5 Feb 2020
Sr VP & Chief Business Officer
Sold after exercise
623
$10.00
$6.23K
Risser Eric Blasius
4 Feb 2020
Sr VP & Chief Business Officer
Sold after exercise
30
$10.00
$300.00
Karrels James
30 Jan 2020
SVP, CFO and Secretary
Exercised, kept
5,180
$0.94
$4.87K
Karrels James
30 Jan 2020
SVP, CFO and Secretary
Exercised, kept
7,320
$0.94
$6.88K
Risser Eric Blasius
27 Sep 2019
Sr VP & Chief Business Officer
Exercised, kept
1,662
$0.94
$1.56K
Risser Eric Blasius
22 May 2019
Sr VP & Chief Business Officer
Sold after exercise
1,000
$19.03
$19.03K
Risser Eric Blasius
20 May 2019
Sr VP & Chief Business Officer
Sold after exercise
3,000
$18.38
$55.13K
Risser Eric Blasius
14 Mar 2019
Sr VP & Chief Business Officer
Exercised, kept
2,497
$0.94
$2.35K
Spitznagel Thomas
6 Feb 2019
Sr VP, BPD & Manufacturing
Sold after exercise
1,770
$30.00
$53.10K
Peters Jeffrey Stuart
6 Feb 2019
General Counsel
Sell
68
$30.00
$2.04K
Fust Matthew K
6 Feb 2019
Director
Sold after exercise
6,924
$29.38
$203.43K
Risser Eric Blasius
28 Jan 2019
Sr VP & Chief Business Officer
Exercised, kept
6,000
$0.94
$5.64K
Karrels James
24 Jan 2019
SVP, CFO and Secretary
Exercised, kept
2,000
$0.94
$1.88K
Karrels James
24 Jan 2019
SVP, CFO and Secretary
Exercised, kept
5,326
$0.94
$5.01K
Karrels James
8 Jan 2019
SVP, CFO and Secretary
Exercised, kept
5,314
$0.94
$5.00K
Koenig Scott
3 Jan 2019
President and CEO
Exercised, kept
39,897
$0.94
$37.50K
Karrels James
18 Dec 2018
SVP, CFO and Secretary
Exercised, kept
5,000
$0.94
$4.70K
Risser Eric Blasius
12 Dec 2018
Sr VP & Chief Business Officer
Exercised, kept
5,000
$0.94
$4.70K
Karrels James
27 Nov 2018
SVP, CFO and Secretary
Exercised, kept
3,000
$0.94
$2.82K
Koenig Scott
13 Nov 2018
President and CEO
Exercised, kept
40,000
$0.94
$37.60K
Risser Eric Blasius
13 Nov 2018
Sr VP & Chief Business Officer
Exercised, kept
4,000
$0.94
$3.76K
Risser Eric Blasius
22 Oct 2018
Sr VP & Chief Business Officer
Exercised, kept
3,000
$0.94
$2.82K
Risser Eric Blasius
12 Mar 2018
Sr VP & Chief Business Officer
Sold after exercise
1,000
$31.08
$31.08K
Karrels James
5 Mar 2018
SVP, CFO and Secretary
Sell
5,000
$31.00
$155.00K
Risser Eric Blasius
2 Mar 2018
Sr VP & Chief Business Officer
Sold after exercise
4,000
$30.00
$120.00K
Cilinski Lynn
28 Feb 2018
VP, Controller and Treasurer
Sold after exercise
23,967
$25.01
$599.44K
Risser Eric Blasius
28 Feb 2018
Sr VP & Chief Business Officer
Sold after exercise
1,000
$25.01
$25.01K
Risser Eric Blasius
24 Jan 2018
Sr VP & Chief Business Officer
Sold after exercise
3,000
$22.50
$67.50K
Risser Eric Blasius
17 Jan 2018
Sr VP & Chief Business Officer
Exercised, kept
2,000
$0.94
$1.88K
Wigginton Jon Marc
17 Jan 2018
Sr VP, Clinical Dev. & CMO
Sold after exercise
2,524
$20.00
$50.48K
Wigginton Jon Marc
16 Jan 2018
Sr VP, Clinical Dev. & CMO
Sold after exercise
2,476
$20.00
$49.52K
Karrels James
16 Jan 2018
SVP, CFO and Secretary
Exercised, kept
6,516
$0.94
$6.13K
Karrels James
29 Dec 2017
SVP, CFO and Secretary
Exercised, kept
3,000
$0.94
$2.82K
Wigginton Jon Marc
21 Nov 2017
Sr VP, Clinical Dev. & CMO
Sold after exercise
5,000
$20.00
$100.00K
Wigginton Jon Marc
25 Oct 2017
Sr VP, Clinical Dev. & CMO
Sold after exercise
10,000
$20.00
$200.00K
Risser Eric Blasius
5 Sep 2017
Sr VP & Chief Business Officer
Exercised, kept
2,000
$0.94
$1.88K
Karrels James
5 Sep 2017
SVP, CFO and Secretary
Exercised, kept
5,000
$0.94
$4.70K
Bonvini Ezio
26 Jul 2017
Sr VP, Research & CSO
Exercised, kept
26,632
$0.94
$25.03K
Bonvini Ezio
26 Jul 2017
Sr VP, Research & CSO
Exercised, kept
26,632
$1.51
$40.21K
Wigginton Jon Marc
5 Jun 2017
Sr VP, Clinical Dev. & CMO
Sold after exercise
5,000
$20.00
$100.00K
Wigginton Jon Marc
19 Apr 2017
Sr VP, Clinical Dev. & CMO
Sold after exercise
15,000
$20.00
$300.00K
Karrels James
25 Jan 2017
SVP, CFO and Secretary
Exercised, kept
5,000
$0.94
$4.70K
Koenig Scott
17 Jan 2017
President and CEO
Exercised, kept
79,898
$0.94
$75.10K
Bonvini Ezio
19 Oct 2016
Sr VP, Research & CSO
Exercised, kept
5,349
$0.94
$5.03K
Cilinski Lynn
3 Oct 2016
VP, Controller and Treasurer
Sold after exercise
6,231
$29.28
$182.44K
Wigginton Jon Marc
3 Oct 2016
Sr VP, Clinical Dev. & CMO
Sold after exercise
10,000
$29.34
$293.40K

What was left out

Form 4 filings counted 317
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 54
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 2,847,434
Sales filed before the plan box existed 8
History held since 16 Sep 2016